Close
CDMO Safety Testing 2026
Novotech

Drug Research

Addressing the challenges of BYOD: is the industry over cautious?

Over recent years, the rise of Electronic Clinical Outcome Assessments (eCOA) solutions has opened up a host of opportunities to researchers. By allowing participants to easilyย submit information during a clinical trial via devices such as tablets, computers, handheld devices and...

Digital Science welcomes Gigantum and Ripeta to the family to help increase reproducibility in research

Digital Science, a technology company serving stakeholders across the research ecosystem, welcomes two US-based startups to the Digital Science family of companies: automated reproducibility assessment tool, Ripeta, and data science platform, Gigantum. Both companies are playing...

HYD Pharma Develops New Deuterium-Depleted Drugs for the Treatment of Neoplastic and Metabolic Diseases

Science ignored the presence of the heavy hydrogen, deuterium (D) in living organisms for 60 years since its discovery by Harold C. Urey in the early 30โ€™s, despite the fact, that the concentration of deuterium is 6-time higher than...

Biocartis and Bristol-Myers Squibb Sign Collaboration Agreement for MSI Testing with Immuno-Oncology Therapies

Biocartis Group NV , an innovative molecular diagnostics company announced the signing of a collaboration agreement with Bristol-Myers Squibb Company , a global biopharmaceutical company, aimed at the potential registration as a companion diagnostic and use of the IdyllaTM...

Implementing a more structured approach to analytical method development

The adoption of lifecycle management to ensure the quality of pharmaceutical products has been discussed extensively over recent years. The modern concept of method lifecycle management (MLCM) provides a framework for defining the criteria and development of analytical methods, aiming...

Lonzaโ€™s New Spheroid-Forming Human Hepatocytes Facilitate Improved In Vitro Liver Model Systems

Lonza has further expanded its hepatocytes portfolio characterization with the addition of Verified for Spheroids Human Hepatocytes, which are pre-screened for their ability to promote rapid spheroid formation in cell culture. Researchers working in toxicology, disease...

Sapreme Technologies in Alliance to Develop an Oligonucleotide Delivery Platform

Sapreme Technologies, a privately-held biotech company developing a technology platform to enable the cytosolic delivery of macromolecule therapeutics, has been awarded a 6.8 Mโ‚ฌ grant together with a multidisciplinary consortium including 11 other academic and industrial parties. ...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป